Back to RAPP
TRV GP VI, LLC RAPP Position History
Rapport Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$32.6M
Q3 2026
Peak value
$40.4M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $29.4M |
| Q1 2026 | $30.3M |
| Q2 2026 | $40.4M |
| Q3 2026 | $32.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $32.6M | 969.2K | — | — |
| Q2 2026 | $40.4M | 969.2K | — | — |
| Q1 2026 | $30.3M | 969.2K | — | — |
| Q4 2025 | $29.4M | 969.2K | — | — |
Other funds holding RAPP
$261.7M
$223.3M
$216.5M
$211M
$165.5M
$155.4M
$133.6M
$133.4M